Vinita Gupta Archives - Express Pharma

Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025

Lupin gets USFDA approval for Glycopyrrolate Injection, USP

US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar

Lupin appoints J Alan Butcher as Chief Corporate Development Officer

Lupin acquires Biocom in Russia